Vasculitis 2022 (@vasculitis2022) 's Twitter Profile
Vasculitis 2022

@vasculitis2022

Official Twitter account for the International Vasculitis and ANCA Workshop 2022. 3rd - 6th April 2022.

ID: 1437100463162339328

linkhttps://vasculitis2022.org calendar_today12-09-2021 17:07:45

942 Tweet

1,1K Followers

208 Following

Imperial Vasculitis Centre (@icl_vasculitis) 's Twitter Profile Photo

It is with immense sadness that we announce the death of our co-director, the irreplaceable Professor Justin Mason An online memorial board has been set up for staff, students and peers to share their messages and memories of Professor Justin Mason ow.ly/iuiZ50JhkY5

Juan Carlos Q Velez (@veleznephhepato) 's Twitter Profile Photo

Pt w/RPGN picture, Cr 1.1 3mo prior, arrived w/Cr 4, prot/hem in urine, MPO+ANCA, DAH, AKI-RRT. Deemed too sick for biopsy. Started CS,PLEX, RTX/CYC (RITUXIVAS). 2 wks later, transfers to you, Spun urine RBC casts, still AKI-RRT. 2nd dose RTX/CYC due. You would (vote and comment)

Matthew Rutherford (@nephmatt) 's Twitter Profile Photo

If you'd like to know a little more about the inner machinations of FAIRVASC then check out this short interview I did with our communications team #anca #vasculitis #registry #data 😀

FAIRVASC (@fairvasc) 's Twitter Profile Photo

The EUVAS Registries Group of FAIRVASC research is led by Prof. Mark Little, Trinity College Dublin. They have identified over 11,000 AAV cases in European national registries and defined a common data dictionary. fairvasc.eu/registries/

The <a href="/EUVAS19/">EUVAS</a> Registries Group of <a href="/FAIRVASC/">FAIRVASC</a> research is led by Prof. Mark Little, <a href="/tcddublin/">Trinity College Dublin</a>. They have identified over 11,000 AAV cases in European national registries and defined a common data dictionary. fairvasc.eu/registries/
FAIRVASC (@fairvasc) 's Twitter Profile Photo

Rigorous clinical research relies on the analysis of sufficiently large numbers of patients, samples, measurements etc. to allow reliable statistical inference. The low prevalence of #rarediseases and thus patient numbers represent a major barrier to such research. #vasculitis

Rigorous clinical research relies on the analysis of sufficiently large numbers of patients, samples, measurements etc. to allow reliable statistical inference. The low prevalence of #rarediseases and thus patient numbers represent a major barrier to such research. #vasculitis
EnvisionRheumat (@erheumat) 's Twitter Profile Photo

🆕Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study Interesting🤔➡️ Should lead to some RCTs #MedTwitter #RheumTwitter #Vasculitis ard.bmj.com/content/early/…

🆕Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 
Interesting🤔➡️ Should lead to some RCTs 
#MedTwitter #RheumTwitter #Vasculitis 
ard.bmj.com/content/early/…
Annals of the Rheumatic Diseases (@eular_ard) 's Twitter Profile Photo

Sequential therapy with #rituximab and #mepolizumab for #EGPA: efficacy demonstrated in a retrospective multicenter study of 38 patients. bit.ly/3aYtvAK

Sequential therapy with #rituximab and #mepolizumab for #EGPA: efficacy demonstrated in a retrospective multicenter study of 38 patients. bit.ly/3aYtvAK
Andreas Kronbichler (@akronbichler) 's Twitter Profile Photo

More than grateful that Rheumatology & Rheumatology Advances in Practice invited us to write an Editorial on a very informative paper from Korea (academic.oup.com/rheumatology/a…) about the 2022 classification of GPA. Evolvement of classification criteria has been summarized in this table (see below) academic.oup.com/rheumatology/a…

More than grateful that <a href="/RheumJnl/">Rheumatology & Rheumatology Advances in Practice</a> invited us to write an Editorial on a very informative paper from Korea (academic.oup.com/rheumatology/a…) about the 2022 classification of GPA. Evolvement of classification criteria has been summarized in this table (see below) academic.oup.com/rheumatology/a…
Trinity Kidneys (@thkc1) 's Twitter Profile Photo

Can’t believe we haven’t studied this properly before - Duvuru Geetha sees reduction in #vasculitis relapse in people given #immunoglobulin for hypoglobulinemia. Tiny series but merits validation. doi.org/10.1016/j.kint…

Can’t believe we haven’t studied this properly before - <a href="/DuvuruG/">Duvuru Geetha</a> sees reduction in #vasculitis relapse in people given #immunoglobulin for hypoglobulinemia. Tiny series but merits validation. doi.org/10.1016/j.kint…
Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸 (@kidneydoc101) 's Twitter Profile Photo

So let me get this straight: @KwasiKwarteng & Liz Truss are putting more £ in our pockets so we can pay more for #mortgages, more for anything imported as the £ goes into free fall & have even more underfunding of #PublicSector services? In what universe is any of this good?

FAIRVASC (@fairvasc) 's Twitter Profile Photo

There are many important gaps in our knowledge about why and how #vasculitis occurs, why some people seem to be more susceptible than others, how the disease process acts inside the body and whether different kinds of vasculitis should be treated in different ways. Meet FAIRVASC

FAIRVASC (@fairvasc) 's Twitter Profile Photo

ATTENTION! People w #RareDiseases and #Patientadvocates in the wider FAIRVASC family👪👩‍👧‍👧👨‍👧 📅The deadline is tomorrow to apply to attend Rare Disease Week 2023 in #Brussels at no cost! As it says on the tin🥫: Empower your future self today!

Raffaele Madeo (@dr_madeo) 's Twitter Profile Photo

Prof. Cees Kallenberg from University of Groningen ia giving us the opportunity to take stock of current understanding on #vasculitis here at #EUVAS2022 in #Florence EUVAS Università di Firenze KDIGO Cambridge University @VasculitisUMCG Vasculitis 2022 #AAV #NephTwitter #KidneyDisease

Prof. Cees Kallenberg from <a href="/univgroningen/">University of Groningen</a> ia giving us the opportunity to take stock of current understanding on #vasculitis here at #EUVAS2022 in #Florence
<a href="/EUVAS19/">EUVAS</a> <a href="/UNI_FIRENZE/">Università di Firenze</a> <a href="/goKDIGO/">KDIGO</a> <a href="/Cambridge_Uni/">Cambridge University</a> @VasculitisUMCG
<a href="/Vasculitis2022/">Vasculitis 2022</a> #AAV #NephTwitter #KidneyDisease
Columbia Department of Medicine (@cuimcdeptofmed) 's Twitter Profile Photo

Join us on Friday, March 3, 2023 for the #complimentary virtual program '#ANCA #Vasculitis: Update on Diagnosis & Treatment' Registration: eventleaf.com/e/ANCA2023 #IgAN #Kidney #NephTwitter #NephPearls #KidneyTwitter #Renal #Medicine #MedEd #MedTwitter #Physician #Doctor

Join us on Friday, March 3, 2023 for the #complimentary virtual program '#ANCA #Vasculitis: Update on Diagnosis &amp; Treatment'
Registration:
eventleaf.com/e/ANCA2023

#IgAN #Kidney #NephTwitter #NephPearls #KidneyTwitter #Renal #Medicine #MedEd #MedTwitter #Physician #Doctor